What's in OM Pharma SA's pipeline?

OM Pharma SA has 3 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with OM Pharma SA's portfolio?

Top competitors by shared drug class: Chinese Academy of Medical Sciences, Kecioren Education and Training Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/om-pharma-sa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

OM Pharma SA — Portfolio Competitive Intelligence Brief

OM Pharma SA pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
OM-85	OM-85	marketed			Immunology
Broncho-Vaxom	Broncho-Vaxom	phase 3	Bacterial lysate immunostimulant		Immunology / Respiratory

Therapeutic area mix

Immunology · 1
Immunology / Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Chinese Academy of Medical Sciences · 1 shared drug class
Kecioren Education and Training Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for OM Pharma SA:

Cite this brief

Drug Landscape (2026). OM Pharma SA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/om-pharma-sa. Accessed 2026-05-13.